Rep. Lisa C. McClain Sells Off Shares of Baxter International Inc. (NYSE:BAX)

Representative Lisa C. McClain (R-Michigan) recently sold shares of Baxter International Inc. (NYSE:BAX). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Baxter International stock on October 31st. The trade occurred in the Representative’s “CHARLES SCHWAB 401K > SCHWAB 893” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Baxter International Stock Up 0.2%

Baxter International stock traded up $0.05 during trading hours on Wednesday, hitting $18.71. The company had a trading volume of 2,753,111 shares, compared to its average volume of 5,869,865. The firm has a market capitalization of $9.62 billion, a P/E ratio of -62.35, a price-to-earnings-growth ratio of 0.73 and a beta of 0.57. Baxter International Inc. has a fifty-two week low of $17.40 and a fifty-two week high of $37.74. The company has a debt-to-equity ratio of 1.30, a current ratio of 2.30 and a quick ratio of 1.49. The firm’s fifty day moving average is $21.07 and its 200-day moving average is $25.40.

Baxter International (NYSE:BAX) last posted its earnings results on Thursday, October 30th. The medical instruments supplier reported $0.69 EPS for the quarter, topping the consensus estimate of $0.60 by $0.09. Baxter International had a negative net margin of 1.42% and a positive return on equity of 16.96%. The company had revenue of $2.84 billion during the quarter, compared to the consensus estimate of $2.88 billion. During the same period in the previous year, the firm posted $0.80 earnings per share. The company’s revenue for the quarter was up 5.0% compared to the same quarter last year. Baxter International has set its Q4 2025 guidance at 0.520-0.570 EPS. FY 2025 guidance at 2.350-2.400 EPS. On average, research analysts forecast that Baxter International Inc. will post 2.48 earnings per share for the current year.

Baxter International Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Friday, November 28th will be given a dividend of $0.01 per share. The ex-dividend date of this dividend is Friday, November 28th. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. Baxter International’s payout ratio is presently -6.06%.

Wall Street Analysts Forecast Growth

BAX has been the subject of several analyst reports. The Goldman Sachs Group reduced their target price on Baxter International from $25.00 to $22.00 and set a “neutral” rating for the company in a report on Friday, October 31st. Cowen restated a “hold” rating on shares of Baxter International in a report on Thursday, October 30th. UBS Group cut their price target on Baxter International from $24.00 to $21.00 and set a “neutral” rating for the company in a report on Friday, October 31st. Jefferies Financial Group reduced their price objective on Baxter International from $25.00 to $21.00 and set a “hold” rating for the company in a research report on Thursday, October 30th. Finally, JPMorgan Chase & Co. reduced their target price on Baxter International from $25.00 to $19.00 in a research report on Friday, October 31st. Two analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Reduce” and an average target price of $23.70.

Hedge Funds Weigh In On Baxter International

Several institutional investors have recently modified their holdings of the stock. Horizon Investments LLC grew its stake in shares of Baxter International by 5.0% in the 1st quarter. Horizon Investments LLC now owns 7,438 shares of the medical instruments supplier’s stock valued at $255,000 after buying an additional 351 shares during the period. Creative Financial Designs Inc. ADV boosted its holdings in Baxter International by 169.6% in the second quarter. Creative Financial Designs Inc. ADV now owns 984 shares of the medical instruments supplier’s stock worth $30,000 after acquiring an additional 619 shares in the last quarter. Nicholas Hoffman & Company LLC. grew its stake in Baxter International by 2.0% in the first quarter. Nicholas Hoffman & Company LLC. now owns 31,739 shares of the medical instruments supplier’s stock valued at $1,086,000 after acquiring an additional 636 shares during the period. EverSource Wealth Advisors LLC increased its holdings in shares of Baxter International by 14.4% during the third quarter. EverSource Wealth Advisors LLC now owns 5,448 shares of the medical instruments supplier’s stock valued at $124,000 after acquiring an additional 686 shares in the last quarter. Finally, Anchor Investment Management LLC raised its position in shares of Baxter International by 3.4% during the first quarter. Anchor Investment Management LLC now owns 21,164 shares of the medical instruments supplier’s stock worth $724,000 after purchasing an additional 701 shares during the period. 90.19% of the stock is currently owned by institutional investors and hedge funds.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.